BioSpace News Archive

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health announced that data from SWOG S1826 have been selected as late-breaking presentations at the 2023 American Society of Clinical Oncology Annual Meeting, to be held both in person in Chicago and online from June 2-6.

eMolecules, Inc., an industry leading chemical compound search-and-fulfillment platform for early discovery chemistry research, announced the acquisition of Specs Compound Handling B.V..

Novotech, the leading Asia Pacific centred biotech CRO is sponsoring key oncology focussed expert events for ASCO: a pre-ASCO Summit with eChina Health, and a webinar panel discussion on accelerating development of advanced therapies with Endpoints.

Theratechnologies Inc. announced preliminary efficacy data from a Phase 1 study of its lead investigational peptide-drug conjugate candidate, sudocetaxel zendusortide, in patients with advanced solid tumors.

Aadi Bioscience, Inc. announced poster presentations at the 2023 ASCO Annual Meeting taking place June 2-6, 2023, in Chicago, IL.

HUTCHMED Limited announces that new and updated clinical data related to HUTCHMED’s novel investigational cancer therapies fruquintinib, surufatinib and HMPL-453 in 21 abstracts that will be presented at the upcoming American Society of Clinical Oncology Annual Meeting, taking place June 2-6, 2023 in Chicago, IL and online.

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, reported operational highlights and financial results for the period ended March 31, 2023.

Bristol Myers Squibb announced the first disclosure of results from the primary analysis of the pivotal TRANSCEND CLL 004 study, a Phase 1/2, open-label, single-arm multicenter study evaluating Breyanzi in adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

Geron Corporation, a late-stage clinical biopharmaceutical company, announced acceptance of its IMerge Phase 3 abstract as an oral presentation at the upcoming 2023 American Society of Clinical Oncology Annual Meeting.

Deciphera Pharmaceuticals, Inc. announced four poster presentations at the upcoming 2023 American Society of Clinical Oncology Annual Meeting, being held in Chicago, Illinois on June 2-6, 2023.